22nd Century Group EV - Enterprise Value 2011-2026 | XXII

Annual EV - Enterprise Value 22nd Century Group

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.92 M	13.2 M	36.3 M	27.9 M	491 M	354 M	130 M	295 M	356 M	63.4 M	88.1 M	70.5 M	114 M	34.9 M	17.9 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
491 M	1.92 M	140 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Ultragenyx Pharmaceutical RARE	3.2 B	$ 19.23	-3.85 %	$ 1.9 B	USA
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
RedHill Biopharma Ltd. RDHL	18.1 M	$ 0.8	0.89 %	$ 428 M	Israel
Dr. Reddy's Laboratories Limited RDY	88.4 B	$ 13.56	-1.56 %	$ 2.25 B	India
Regeneron Pharmaceuticals REGN	87.4 B	$ 742.02	-1.94 %	$ 77.6 B	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	22.8 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
Replimune Group REPL	625 M	$ 7.22	-4.24 %	$ 582 M	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
REGENXBIO RGNX	759 M	$ 7.88	-4.6 %	$ 406 M	USA
Aileron Therapeutics ALRN	4.02 M	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	5.65 B	-	-6.81 %	$ 3.04 B	USA
Rigel Pharmaceuticals RIGL	679 M	$ 26.2	-0.64 %	$ 471 M	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	-1.23 M	-	-52.27 %	$ 4.45 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Atreca BCEL	94.8 M	-	-11.76 %	$ 5.79 M	USA
Avidity Biosciences RNA	9.93 B	$ 13.09	-0.08 %	$ 1.8 B	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	270 M	-	-	$ 546 M	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Avid Bioservices CDMO	661 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Rhythm Pharmaceuticals RYTM	6.5 B	$ 78.52	-4.13 %	$ 5.1 B	USA
Adaptive Biotechnologies Corporation ADPT	2.7 B	$ 12.57	-9.96 %	$ 1.91 B	USA
Sana Biotechnology SANA	1.18 B	$ 2.78	-8.42 %	$ 704 M	USA
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
SIGA Technologies SIGA	270 M	$ 5.35	7.76 %	$ 383 M	USA
Alnylam Pharmaceuticals ALNY	43.3 B	$ 321.71	-1.96 %	$ 42.1 B	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	71.1 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	91.4 M	-	-	$ 3.74 B	USA
Silence Therapeutics plc SLN	1.55 B	$ 4.8	-9.6 %	$ 622 M	Britain
Enlivex Therapeutics Ltd. ENLV	122 M	$ 1.08	-0.92 %	$ 22.2 M	Israel
Enochian Biosciences ENOB	145 M	-	-	$ 40.5 M	USA